Broken String Biosciences

Broken String Biosciences

Private
Cambridge, EnglandHealthcare & Life Scienceshttps://www.brokenstringbio.com

Last Round

Series A

Sep 18, 2023

Total Funding Raised

$15M

Momentum Score

50 /100

Company Overview

Broken String Biosciences is a biotechnology company that develops a sequencing platform to enhance the safety and efficacy of cell and gene therapies through advanced sequencing techniques, bioinformatics, and artificial intelligence.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Clinical Trials, Biotech Equipment

Business Model

B2B

Customer Profile

Services & Consulting, Hardware Sales, Subscription SaaS

AI Layer

Application

Keywords

off-target analysisgene editing safetyDNA break mappinggene therapy safetycell and gene therapyCRISPR safetyNext Generation SequencingNGSgenome editinggenomic integritysequencing servicesgene editing QCdrug discovery toolsPCR-freegRNA selection

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Broken String Biosciences Comps

Public and private peers based on sector, stage, and business model.

CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Broken String Biosciences Funding Rounds

Historical fundraising activity

RoundDateAmount RaisedValuationInvestorsSources
Series ASep 18, 2023

Key People

Founding team and executive leadership

Vincent Smith

Chief Technology Officer

Executive Team

Broken String Biosciences Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • May 21, 2026

    Monthly visitors increased 38% MoM.

  • Mar 31, 2026

    Launched new branding and a comprehensive website.

Broken String Biosciences Filings

SEC and related filings with document metadata.

TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Broken String Biosciences Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Broken String Biosciences's valuation, stock price, and market status.

Firmographic Details

HeadquartersCambridge, England
Employee Range36
Year Founded2015
Last FundingSep 18, 2023

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.







Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.